Molecular characterisation of isogenic taxane resistant cell lines identify novel drivers of drug resistance

BACKGROUND: Taxanes such as paclitaxel and docetaxel are used successfully to treat breast cancer, usually in combination with other agents. They interfere with microtubules causing cell cycle arrest; however, the mechanisms underlying the clinical effects of taxanes are yet to be fully elucidated....

Descripción completa

Detalles Bibliográficos
Autores principales: Kenicer, Juliet, Spears, Melanie, Lyttle, Nicola, Taylor, Karen J, Liao, Linda, Cunningham, Carrie A, Lambros, Maryou, MacKay, Alan, Yao, Cindy, Reis-Filho, Jorge, Bartlett, John MS
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2014
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4203938/
https://www.ncbi.nlm.nih.gov/pubmed/25312014
http://dx.doi.org/10.1186/1471-2407-14-762

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4203938/
https://www.ncbi.nlm.nih.gov/pubmed/25312014
http://dx.doi.org/10.1186/1471-2407-14-762

Ejemplares similares